Wednesday, July 06, 2022 9:31:25 PM
Bullish
7/4/22, 06:26 PM
$RGBP
- Here's something that needs to be said. Something is DEFINITELY going on behind the scenes with Dr Koos prolonged silence and no updates on the Fast Track IND. It's my discernment Koos is at the negotiating table with more than one suitor working out the details of either an out right cash purchase OR Merger/Acquisition. A major indicator of that is related to his PR some time ago that "several individuals" requested updates of the Company's IP. Common sense dictates that such "individuals" are either Big Pharma CEOs and/or a Start Up Pharma looking to Turn Key a portfolio of highly marketable IP from the get go foregoing decades of research. No single investor has
$160M
to shell out for putting our IND through clinical trials. This is why that IND is still sitting there with no news of it moving into trials. Not only this, it takes an enormous amount liquid cash, man power, and expertise for that to happen which apparently Oncology Pharma is lacking. All feedback welcome.
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM